Recent advances in CAR-T cell engineering
Recent advances in CAR-T cell engineering
About this item
Full title
Author / Creator
Huang, Ruihao , Li, Xiaoping , He, Yundi , Zhu, Wen , Gao, Lei , Liu, Yao , Gao, Li , Wen, Qin , Zhong, Jiang F. , Zhang, Cheng and Zhang, Xi
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Chimeric antigen receptor T (CAR-T) cell therapy is regarded as an effective solution for relapsed or refractory tumors, particularly for hematological malignancies. Although the initially approved anti-CD19 CAR-T therapy has produced impressive outcomes, setbacks such as high relapse rates and resistance were experienced, driving the need to disco...
Alternative Titles
Full title
Recent advances in CAR-T cell engineering
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e63d904f3d1b45e0a7f5550fb95e543c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e63d904f3d1b45e0a7f5550fb95e543c
Other Identifiers
ISSN
1756-8722
E-ISSN
1756-8722
DOI
10.1186/s13045-020-00910-5
